AARON SAGUIL, MD, MPH, SHAWN KANE, MD, MICHAEL MERCADO, MD, AND REBECCA LAUTERS, MD Am Fam Physician. 2017;96(10):656-663 NOTE: On October 25, 2017, the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices voted to recommend the herpes zoster recombinant subunit vaccine (Shingrix) for healthy adults 50 years and older, including those who previously received Zostavax, to prevent shingles and related complications. This article has been revised to reflect the new recommendations. Читать дальше...